TY - GEN
T1 - DEEP UNSUPERVISED CLUSTERING OF SPARSE ECHO DATA TO IDENTIFY PATIENTS FOR IMPLANTATION OF CARDIOVERTER-DEFIBRILLATOR
AU - Enayati, Moein
AU - Farahani, Nasibeh Zanjirani
AU - Scott, Christopher G.
AU - Bos, Johan M.
AU - Yao, Xiaoxi
AU - Ngufor, Che G.
AU - Ackerman, Michael John
AU - Arruda-Olson, Adelaide
N1 - Publisher Copyright:
© 2022 by ASME
PY - 2022
Y1 - 2022
N2 - According to the 2020 report of the American Heart Association's Heart & Stroke Statistics report, nearly 1,000 people are dying daily because of sudden out-of-hospital cardiac arrests and unfortunately, their survival rate is as low as 10%. Hypertrophic Cardiomyopathy (HCM), a relatively rare genetic heart disease is one of these diseases but finding the right patient for the implantation of ICD is still a research question. Implantation of cardioverter-defibrillator (ICD) can save the life of some of these patients. Due to the complexity of the identification of HCM patients, financial burdens, and the clinical risks involved in the ICD implantation procedure, HCM patients will go into a monitoring state before reaching the implantation trigger. Our study cohort shows about 82% of HCM deaths, did not have an ICD, which highlights the need to improve the pre-screening algorithms. In the current paper, we have proposed a new deep learning-based unsupervised clustering technique to facilitate the prioritization of patients to undergo ICD device implantation. This model uses over 900 echocardiographic measurements to find patients who benefit more from the ICD implantation procedure. Our model was trained and tested over 6 years of echo reports collected at Mayo Clinic. This model can be used as a decision support assistant for cardiologists in finding the right HCM patient when decision-making is hard.
AB - According to the 2020 report of the American Heart Association's Heart & Stroke Statistics report, nearly 1,000 people are dying daily because of sudden out-of-hospital cardiac arrests and unfortunately, their survival rate is as low as 10%. Hypertrophic Cardiomyopathy (HCM), a relatively rare genetic heart disease is one of these diseases but finding the right patient for the implantation of ICD is still a research question. Implantation of cardioverter-defibrillator (ICD) can save the life of some of these patients. Due to the complexity of the identification of HCM patients, financial burdens, and the clinical risks involved in the ICD implantation procedure, HCM patients will go into a monitoring state before reaching the implantation trigger. Our study cohort shows about 82% of HCM deaths, did not have an ICD, which highlights the need to improve the pre-screening algorithms. In the current paper, we have proposed a new deep learning-based unsupervised clustering technique to facilitate the prioritization of patients to undergo ICD device implantation. This model uses over 900 echocardiographic measurements to find patients who benefit more from the ICD implantation procedure. Our model was trained and tested over 6 years of echo reports collected at Mayo Clinic. This model can be used as a decision support assistant for cardiologists in finding the right HCM patient when decision-making is hard.
KW - Deep learning
KW - Echocardiography
KW - Hypertrophy Cardiomyopathy
KW - Implantable Cardioverter-Defibrillator
KW - Sparse Unsupervised Auto-Encoder
UR - http://www.scopus.com/inward/record.url?scp=85130248335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130248335&partnerID=8YFLogxK
U2 - 10.1115/DMD2022-1074
DO - 10.1115/DMD2022-1074
M3 - Conference contribution
AN - SCOPUS:85130248335
T3 - Proceedings of the 2022 Design of Medical Devices Conference, DMD 2022
BT - Proceedings of the 2022 Design of Medical Devices Conference, DMD 2022
PB - American Society of Mechanical Engineers
T2 - 2022 Design of Medical Devices Conference, DMD 2022
Y2 - 11 April 2022 through 14 April 2022
ER -